PSCH holdings and overlap
Invesco S&P SmallCap Health Care ETF (PSCH) holds 69 positions in its Invesco file of 2026-10-24. Its three largest are Glaukos (GKOS) at 5.53%, Protagonist Therapeutics (PTGX) at 4.69% and TG Therapeutics (TGTX) at 4.03%, and its ten largest make up 34.9% of the fund.
In its Invesco file of 2026-10-24, PSCH is 100.0% health care by sector, with none of it in mega-cap tech or in the ten largest US companies by market value.
What does PSCH hold, as of its issuer file of 2026-10-24?
Glaukos is 5.53% of PSCH on its own, against a median largest position of 8.6% across the 28 Health Care funds with a page here. No fund with a page here holds more GKOS than PSCH does, out of the 45 that hold it at all.
| Rank | Company | Weight | Weight bar |
|---|---|---|---|
| 1 | GKOS Glaukos | 5.53% | |
| 2 | PTGX Protagonist Therapeutics | 4.69% | |
| 3 | TGTX TG Therapeutics | 4.03% | |
| 4 | ALKS Alkermes | 3.83% | |
| 5 | LGND Ligand Pharmaceuticals | 3.17% | |
| 6 | TFX Teleflex | 3.03% | |
| 7 | MMSI Merit Medical Systems | 2.92% | |
| 8 | PTCT PTC Therapeutics | 2.65% | |
| 9 | RDNT RadNet | 2.61% | |
| 10 | CON Concentra Group Holdings Parent | 2.44% | |
| 11 | ITGR Integer | 2.25% | |
| 12 | ICUI ICU Medical | 2.18% | |
| 13 | INDV Indivior Pharmaceuticals | 2.13% | |
| 14 | VCYT Veracyte | 2.02% | |
| 15 | AMRX Amneal Pharmaceuticals | 1.97% | |
| 16 | OGN Organon | 1.89% | |
| 17 | ARQT Arcutis Biotherapeutics | 1.87% | |
| 18 | LFST LifeStance Health Group | 1.83% | |
| 19 | WAY Waystar | 1.83% | |
| 20 | LQDA Liquidia | 1.66% | |
| 21 | NHC National HealthCare | 1.57% | |
| 22 | ATRC AtriCure | 1.57% | |
| 23 | ACHC Acadia Healthcare | 1.54% | |
| 24 | PRVA Privia Health Group | 1.5% | |
| 25 | NEOG Neogen | 1.39% | |
| 26 | CRVL CorVel | 1.35% | |
| 27 | ACAD ACADIA Pharmaceuticals | 1.34% | |
| 28 | TMDX TransMedics Group | 1.29% | |
| 29 | ADMA ADMA Biologics | 1.25% | |
| 30 | SUPN Supernus Pharmaceuticals | 1.24% | |
| 31 | MD Pediatrix Medical Group | 1.22% | |
| 32 | UFPT UFP Technologies | 1.2% | |
| 33 | PBH Prestige Consumer Healthcare | 1.19% | |
| 34 | FTRE Fortrea | 1.18% | |
| 35 | ADUS Addus HomeCare | 1.17% | |
| 36 | PGNY Progyny | 1.16% | |
| 37 | PRGO Perrigo | 1.16% | |
| 38 | VCEL Vericel | 1.14% | |
| 39 | NEO NeoGenomics | 1.12% | |
| 40 | INSP Inspire Medical Systems | 1.08% | |
| 41 | SRPT Sarepta Therapeutics | 0.98% | |
| 42 | AMN AMN Healthcare Services | 0.97% | |
| 43 | LMAT LeMaitre Vascular | 0.94% | |
| 44 | HRMY Harmony Biosciences | 0.94% | |
| 45 | XNCR Xencor | 0.9% | |
| 46 | OMCL Omnicell | 0.9% | |
| 47 | RCUS Arcus Biosciences | 0.88% | |
| 48 | ASTH Astrana Health | 0.82% | |
| 49 | ALHC Alignment Healthcare | 0.79% | |
| 50 | INVA Innoviva | 0.78% | |
| 51 | CNMD CONMED | 0.77% | |
| 52 | ANIP ANI Pharmaceuticals | 0.77% | |
| 53 | PCRX Pacira BioSciences | 0.76% | |
| 54 | AZTA Azenta | 0.75% | |
| 55 | SDGR Schrodinger | 0.71% | |
| 56 | VIR Vir Biotechnology | 0.7% | |
| 57 | USPH U.S. Physical Therapy | 0.69% | |
| 58 | ENOV Enovis | 0.64% | |
| 59 | TNDM Tandem Diabetes Care | 0.64% | |
| 60 | CERT Certara | 0.61% | |
| 61 | AORT Artivion | 0.6% | |
| 62 | QDEL QuidelOrtho | 0.49% | |
| 63 | HSTM HealthStream | 0.43% | |
| 64 | PAHC Phibro Animal Health | 0.43% | |
| 65 | AMPH Amphastar Pharmaceuticals | 0.41% | |
| 66 | IART Integra LifeSciences | 0.41% | |
| 67 | COLL Collegium Pharmaceutical | 0.39% | |
| 68 | STAA STAAR Surgical | 0.36% | |
| 69 | AHCO AdaptHealth | 0.34% |
The most recent file Invesco has published for PSCH is dated 2026-10-24, 4 days before these prices, which is the median for the Invesco ETFs covered here. Every one of the 69 positions PSCH holds, with its weight, is in the fund's JSON file. See the other 44 ETFs with a page here that hold GKOS, and how their weights compare with the 5.53% PSCH gives it.
Category: Health Care, set by TickerInside from the ETF's own latest file. In its file of 2026-10-24, 100% of its stocks whose sector is known are health care companies, each in the sector the site gives that company. How categories are set.
https://tickerinside.com/api/v1/fund/psch.jsonhttps://tickerinside.com/api/v1/fund/psch.csv=IMPORTDATA("https://tickerinside.com/api/v1/fund/psch.csv")If your sheet uses a decimal comma: =IMPORTDATA("https://tickerinside.com/api/v1/fund/psch.csv"; ","; "en_US")curl -s https://tickerinside.com/api/v1/fund/psch.jsonHow much money went into or out of PSCH?
On the close of Friday, October 23, 2026, $2.2 million went into PSCH, 1.24% of its assets, as it created shares. Over its last 5 closes, a net outflow of $7.9 million.
From PSCH's own holdings files. Every ETF's latest flows.
How is PSCH split by sector?
| Sector | Weight | Weight bar |
|---|---|---|
| Health care | 100.0% |
From its Invesco file of 2026-10-24. How these are measured.
What did PSCH hold in its SEC reports since 2019?
In PSCH's SEC filings, its largest position went from Arrowhead Pharmaceuticals, Inc. (ARWR) at 6.74% on 2019-11-30 to Molina Healthcare Inc (MOH) at 4.77% on 2026-05-31, across 27 quarterly reports.
| Report | Positions | Largest | Top 10 |
|---|---|---|---|
| 2019-11-30 | 75 | ARWR 6.74% | 36.5% |
| 2020-11-30 | 70 | NEO 5.50% | 34.6% |
| 2021-11-30 | 80 | OMCL 6.14% | 32.7% |
| 2022-11-30 | 81 | AMN 5.30% | 33.5% |
| 2023-11-30 | 68 | ENSG 6.01% | 33.5% |
| 2024-11-30 | 72 | GKOS 4.81% | 33.9% |
| 2025-11-30 | 73 | CORT 4.09% | 32.6% |
| 2026-05-31 | 76 | MOH 4.77% | 35.8% |
The first report, then the last of each year, of the 27 reports PSCH filed on SEC Form N-PORT from 2019-11-30 to 2026-05-31, each company under its ticker today. Every position of every report is in its quarterly file, and at any date at /api/v1/history/psch/{date}.json. How these are read.
What does PSCH share with other ETFs?
The ETF nearest to PSCH is XSMO: the two hold 20.3% of their weight in common, in the 16 companies both own, and 35.5% of PSCH itself is also held there. No covered ETF holds more than that in common with PSCH; it duplicates nothing here closely.
| ETF | Overlap by weight | Of PSCH held there | Of that ETF in PSCH | Companies in both | Overlap bar |
|---|---|---|---|---|---|
| XSMO | 20.3% | 35.5% | 20.3% | 16 | |
| XHE | 20.2% | 28.2% | 29.8% | 19 | |
| XHS | 19.7% | 21.1% | 27.7% | 16 | |
| XPH | 17.5% | 18.9% | 29.5% | 15 | |
| SLYG | 15.9% | 80.1% | 15.9% | 52 | |
| PBE | 13.3% | 17.2% | 19.7% | 8 | |
| PJP | 12.0% | 12.0% | 27.0% | 9 | |
| PTH | 11.6% | 16.3% | 11.9% | 9 | |
| VIOG | 11.5% | 75.0% | 11.5% | 49 | |
| SPSM | 11.1% | 100.0% | 11.1% | 69 | |
| IJR | 11.0% | 100.0% | 11.2% | 69 | |
| XBI | 10.9% | 26.3% | 10.9% | 13 |
VIOG's holdings are from its SEC Form N-PORT for the period ended 2026-05-31, filed 2026-07-29. The other ETFs' holdings are from their issuers' latest files. Check PSCH against any ETF in the ETF overlap calculator · how overlap is measured.
What adds something different to PSCH?
SOXX shares 0% of weight with PSCH and its weekly returns correlate with it at 0.36 over three years. The table lists the covered ETFs with the least in common with PSCH, least shared weight first and, among equals, lowest correlation.
| ETF | Name | Overlap by weight | Correlation, 3y | Companies in both |
|---|---|---|---|---|
| SOXX | iShares Semiconductor ETF | 0.0% | 0.36 | 0 |
| THRO | iShares U.S. Thematic Rotation Active ETF | 0.0% | 0.52 | 1 |
| IYR | iShares U.S. Real Estate ETF | 0.0% | 0.58 | 0 |
| VLUE | iShares MSCI USA Value Factor ETF | 0.0% | 0.59 | 0 |
| URTH | iShares MSCI World ETF | 0.0% | 0.59 | 0 |
| USRT | iShares Core U.S. REIT ETF | 0.0% | 0.59 | 0 |
| REET | iShares Global REIT ETF | 0.0% | 0.61 | 0 |
| USMV | iShares MSCI USA Min Vol Factor ETF | 0.0% | 0.62 | 0 |
Cost, returns and risk
| Expense ratio | 0.29% |
|---|---|
| Dividend yield | 0.00% |
| Total return, 1 year | 30.1% |
| Total return, 3 years cumulative | 51.3% |
| Total return, 5 years cumulative | -13.7% |
| Volatility, annualised | 19.3% |
| Worst fall, 3 years | -20.8% |
| Beta against SPY, 3 years of weekly returns | 0.78 |
| Weight in the ten largest positions | 34.9% |
| Largest single position | 5.5% |
| Assets under management | $0.2B |
Expense ratio, yield and assets are reference data (the expense ratio from PSCH's SEC filing of 2025-12-18); the weight in the ten largest positions and the largest single position are from the issuer file of 2026-10-24; every other figure is computed here from weekly closes.
How it moves with the market
| Against | Correlation, 3 years | Covariance, annualised, in percent squared |
|---|---|---|
| SPY | 0.56loosely linked | 150 |
| QQQ | 0.44loosely linked | 164 |
Weekly total returns. What the bands mean · why the covariance is printed.
Year by year
| Year | Total return |
|---|---|
| 2026 | 25.0% |
| 2025 | -0.5% |
| 2024 | 3.8% |
| 2023 | -2.7% |
| 2022 | -26.5% |
One year
Where to go next
- PTH, Invesco Dorsey Wright Healthcare Momentum ETF
- RSPH, Invesco S&P 500 Equal Weight Health Care ETF
- VHT, Vanguard Health Care ETF
- XBI, SPDR S&P Biotech ETF
- Run a portfolio x-ray to see what PSCH carries once you look through it
- Compare PSCH against any other ETF in the builder
Holdings from the most recent file Invesco has published, dated 2026-10-24. Prices through 2026-10-28. How every figure here is produced. Measurements, not investment advice.
Cite this page
TickerInside, Invesco S&P SmallCap Health Care ETF (PSCH), holdings from the issuer's file of 2026-10-24, https://tickerinside.com/etf/psch/, CC BY 4.0
<a href="https://tickerinside.com/etf/psch/">TickerInside</a> (https://tickerinside.com/etf/psch/)